Important COVID-19 updates and latest data
Keeping patients safe
Find alerts, policies and guidance to keep transplant patients safe and reduce the risk for disease transmission here:
Patient safety resources
PDDTE policy changes – effective 9/1/2016
- Policy notice
- Pathogens of special interest
- FDA-cleared assays, used to determine toxoplasmosis immune status or diagnosis
- Zika virus information for organ donation and transplant professionals (7/2016)
- Frequently asked questions about the 2013 PHS guideline
- West Nile Virus risk factors and evaluating potential living donors
- Recognizing central nervous system infections in potential deceased organ donors
- HTLV-1 screening and confirmation in potential donors and reporting potential HTLV-1 infection
- Recognizing seasonal and geographically endemic infections in organ donors; considerations during living donor evaluation
- OPTN policy 5: organ offers, acceptance, and verification (6/2016)
- System changes related to ABO verification policy are now in place (6/2016)
- OPO Pre-Recovery Verification Template (added 6/28/2016)
- ABO Subtyping Organ Donors for Blood Groups A and AB
- Living Donor OR Verification template (revised 5/2017)
- Recipient OR Verification template (revised 5/2017)
- ABO donor recipient compatibility chart (added 4/2016)
- Electronic Medical Record (EMR) suggested data fields (revised 5/2016)
- Update for OPOs about TransNet labels for extra vessels (12/4/2018)
- Updated vessel labels – 2 x 4 (8/1/2018)
- Updated vessel labels – 2 x 5 (8/1/2018)
- OPOs must use sterile internal labels for extra vessels beginning 9/1/2015 (Updated 2/1/2019)
- Policy 16: Organ and Vessel Packaging, Labeling, Shipping, and Storage
Root cause analysis
Important patient safety notices
If an organ donor tests positive for carbapenem-resistant enterobacteriaceae, coronavirus or influenza, they must be reported in the UNet Improving Patient Safety portal as a potential donor-derived disease transmission event.
The new adult elective surgery and procedure guidelines prioritizes transplant surgeries as essential care.
Recall affects specified lots of Organ Recovery Systems’ LKT200 Perfusion Circuit Sample Port
A manufacturer of retail drugs has issued a voluntary recall of a product used in recovery and preparation of donor lungs.
ICU Medical Inc. has issued a voluntary recall for four specified lots of intravenous sodium chloride solutions and one specified lot of intravenous dextrose solution due to the potential for flexible container leaks.
You now have self-serve access through the Secure Enterprise homepage to update your institution’s patient safety contact information. Please take a moment to review your contact listing and update any out-of-date information.
Our patient safety series includes topics related to extra vessels handling and storage, proactively averting errors, ABO verification in the OR, hemodilution errors and more.
Bridge to Life Ltd. and Waters Medical Systems have issued a field correction for specified lots of Belzer UW Cold Storage Solution and IGL Cold Storage Solution in 2-liter bags.
Find multiple resources to help you apply the 2013 PHS Guideline recommendations and any OPTN safety-related policy to your current practices.
Transplant professionals need to review the recently updated Notes section of the Pathogens of Special Interest document. If one of your recipients tests positive for HCV after their transplant, and they received an organ from an HCV Ab positive/NAT negative donor,...